Secondary cutaneous involvement by systemic anaplastic lymphoma kinase‐negative anaplastic large‐cell lymphoma with 6p25.3 rearrangement

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|67|6|932-935

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.67, Iss.6, 2015-12, pp. : 932-935

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cutaneous involvement in systemic anaplastic large cell lymphoma

By  

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 7, 2015-07 ,pp. : 693-694

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features

By  

HISTOPATHOLOGY, Vol. 66, Iss. 6, 2015-05 ,pp. : 846-855

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brentuximab vedotin is an effective therapy for CD30+ mycosis fungoides and cutaneous anaplastic large‐cell lymphoma: what is the cost?

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1474-1475

John Wiley & Sons Inc

Access to resources Recommend Favorite

ALK‐positive anaplastic large cell lymphoma with prominent bone involvement

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 443-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 65, Iss. 4, 2018-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite